(Q37763786)

22 August 2017

1 reference

title

Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting (English)

1 reference

22 August 2017

1 reference

Antonio González-Martín

series ordinal

1

1 reference

PubMed ID

20534397

22 August 2017

Gemma Toledo

series ordinal

2

1 reference

PubMed ID

20534397

22 August 2017

Luis Chiva

series ordinal

3

1 reference

22 August 2017

1 June 2010

1 reference

Clinical and Translational Oncology

22 August 2017

1 reference

22 August 2017

12

1 reference

22 August 2017

6

1 reference

22 August 2017

418-430

1 reference

https://scigraph.springernature.com/pub.10.1007/s12094-010-0529-1

22 August 2017

0 references

cites work

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-010-0529-1

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-010-0529-1

When should surgical cytoreduction in advanced ovarian cancer take place?

21 January 2018

1 reference

12 December 2020

From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.

1 reference

12 December 2020

Treatment guidelines in ovarian cancer.

1 reference

12 December 2020

Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review

1 reference

12 December 2020

Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: follow-up of a Southwest Oncology Group and Gynecologic

1 reference

12 December 2020

Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials

1 reference

12 December 2020

Ovarian carcinomas, including secondary tumors: diagnostically challenging areas

1 reference

12 December 2020

Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications

1 reference

12 December 2020

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

12 December 2020

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

1 reference

12 December 2020

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

12 December 2020

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

1 reference

12 December 2020

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

12 December 2020

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients

1 reference

12 December 2020

Cancer statistics, 2009

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of recurrent disease: randomized trials of monotherapy versus combination chemotherapy

1 reference

12 December 2020

Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer

1 reference

12 December 2020

Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma

1 reference

12 December 2020

Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment

1 reference

12 December 2020

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

1 reference

12 December 2020

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

1 reference

12 December 2020

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

12 December 2020

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

1 reference

12 December 2020

Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features

1 reference

12 December 2020

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study

1 reference

12 December 2020

Secondary surgical cytoreduction for advanced ovarian carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Selected miscellaneous ovarian lesions: small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions

1 reference

12 December 2020

Frequency of symptoms of ovarian cancer in women presenting to primary care clinics

1 reference

12 December 2020

Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel

1 reference

12 December 2020

Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update

1 reference

12 December 2020

Laparoscopy versus laparotomy for benign ovarian tumour

1 reference

12 December 2020

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

1 reference

12 December 2020

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

12 December 2020

Current status of anti-angiogenic agents in the treatment of ovarian carcinoma.

1 reference

12 December 2020

Intraperitoneal chemotherapy in ovarian cancer remains experimental

1 reference

12 December 2020

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

1 reference

12 December 2020

Intraperitoneal chemotherapy for optimally debulked advanced ovarian cancer: a new standard in patient care?

1 reference

12 December 2020

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

12 December 2020

My approach to and thoughts on the typing of ovarian carcinomas

1 reference

12 December 2020

Histologic subtypes of ovarian carcinoma: an overview.

1 reference

12 December 2020

The biology of ovarian cancer: new opportunities for translation

1 reference

12 December 2020

Anti-angiogenic therapy in ovarian cancer: a great expectation to be confirmed

1 reference

12 December 2020

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

1 reference

12 December 2020

Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis

1 reference

12 December 2020

Ovarian carcinoma pathology and genetics: recent advances

1 reference

12 December 2020

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

1 reference

12 December 2020

Histopathologic grading of ovarian carcinoma: a review and proposal

1 reference

12 December 2020

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

1 reference

12 December 2020

10.1007/S12094-010-0529-1

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20534397